Cite
HARVARD Citation
Harrison, T. et al. (2021). Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. Lancet. 9 (3), pp. 260-274. [Online].